ConductScience.org, home

Trial · NCT07889635

The Effects of an Empower_ICE-Fit Program in PLwD Living at Home

NCT07889635, Not applicable, Not yet recruiting, The University of Hong Kong

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effects of an Empower_ICE-Fit Program in PLwD Living at Home. Trials, record NCT07889635. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889635

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effects of an Empower_ICE-Fit Program in PLwD Living at Home
NCT number
NCT07889635
Status
Not yet recruiting
Phases
Not applicable
Enrollment
304 participants, estimated
Lead sponsor
The University of Hong Kong
Conditions
Dementia
Interventions
empowerment-based Intrinsic capacity-Environment Fit, Usual Care Group
First posted
2026-10-22
Last updated
2026-10-22

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Functional Performance (A-IADL-Q-SV)Baseline, 8 weeks, and 12 weeks
Functional performance is evaluated using the Chinese version of the Amsterdam IADL Questionnaire-Short Version (A-IADL-Q-SV). This tool assesses the difficulties individuals experience in instrumental activities of daily living. A higher score indicates a higher level of functional performance and greater independence, representing a better outcome.
PrimaryChange in Neuropsychiatric Symptoms (NPI-Q-C)Baseline, 8 weeks, and 12 weeks
Neuropsychiatric symptoms are evaluated using the Chinese version of the Neuropsychiatric Inventory Questionnaire (NPI-Q-C). This tool assesses 12 behavioral and psychological symptoms common in dementia. The total symptom severity score is the sum of the severity ratings for all 12 items, ranging from 0 to 36 (each item scored from 0 to 3). A higher score indicates more severe neuropsychiatric symptoms, representing a worse outcome.
PrimaryChange in Social Engagement and Independence (EID-Q-C)Baseline, 8 weeks, and 12 weeks
Social engagement and independence are evaluated using the Chinese version of the Engagement and Independence in Dementia Questionnaire (EID-Q-C). This tool assesses the individual's level of meaningful activity and social interaction. A higher score indicates a greater level of social engagement and independence, representing a better outcome.
SecondaryChange in Participant Quality of Life (QoL-AD)Baseline, 8 weeks, and 12 weeks
Participant quality of life is evaluated using the Quality of Life in Alzheimer's Disease (QoL-AD) scale. This tool assesses various domains of well-being, including physical health, mood, and relationships. Assuming the standard 13-item version is used, the total score ranges from 13 to 52. A higher score indicates a better quality of life, representing a better outcome.
SecondaryChange in Caregiver Quality of Life (SF-12)Baseline, 8 weeks, and 12 weeks
Caregiver health-related quality of life is evaluated using the 12-Item Short Form Health Survey (SF-12). This survey yields a Physical Component Summary (PCS) and a Mental Component Summary (MCS). Scores are typically transformed and standardized to range from \[0\] to \[100\]. A higher score indicates a better physical and mental health status, representing a better outcome.
SecondaryChange in Fear of Falling (FES-I)Baseline, 8 weeks, and 12 weeks
The fear of falling is evaluated using the Falls Efficacy Scale-International (FES-I). This tool assesses an individual's concern about falling during 16 physical and social activities. The total score ranges from 16 to 64. A higher score indicates a greater fear of falling and lower confidence in performing daily activities, representing a worse outcome.
SecondaryChange in Caregiver Burden (ZBI)Baseline, 8 weeks, and 12 weeks
Caregiver burden is evaluated using the Zarit Burden Interview (ZBI). This tool assesses the physical, psychological, and social stresses experienced by family caregivers. Assuming the short 12-item version is used, the total score ranges from 0 to 48. A higher score indicates a greater level of perceived caregiver burden, representing a worse outcome.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07889635

GET https://conductscience.org/api/trials/v1/NCT07889635/registered